有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-[[4-cyclopropyl-5-[(3S)-piperidin-3-yl]-1,2,4-triazol-3-yl]sulfanyl]pyrimidine | —— | C14H18N6S |
|
—— | 1-[2-(4-Methylphenyl)sulfanylethyl]-3-(2-morpholin-4-ylethyl)thiourea | —— | C16H25N3OS2 |
|
—— | 3-[(3S)-1-(2-phenylsulfanylethyl)piperidin-3-yl]propanamide | —— | C16H24N2OS |
|
—— | 1-[(3S)-1-(2-phenylsulfanylethyl)piperidin-3-yl]pyrrolidin-2-one | —— | C17H24N2OS |
|
—— | 3-[(3R)-1-(2-phenylsulfanylethyl)piperidin-3-yl]propanamide | —— | C16H24N2OS |
|
—— | 1-[(3R)-1-(2-phenylsulfanylethyl)piperidin-3-yl]pyrrolidin-2-one | —— | C17H24N2OS |
|
—— | (3R)-3-(1,3-dioxolan-2-yl)-1-(2-phenylsulfanylethyl)piperidine | —— | C16H23NO2S |
|
—— | methyl (2S)-2-[[5-(3-methylthiophen-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-2-phenylacetate | —— | C16H14N2O3S2 |
|
—— | methyl (2S)-2-phenyl-2-[[5-(thiophen-2-ylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetate | —— | C16H14N2O3S2 |
|
—— | 1-[2-(4-Chlorophenyl)sulfanylethyl]-3-(2,2,6,6-tetramethylpiperidin-1-ium-4-yl)thiourea | —— | C18H29ClN3S2+ |
|
—— | 1-Benzyl-1-methyl-3-(2-phenylsulfanylethyl)thiourea | —— | C17H20N2S2 |
|
—— | 1-Cyclopentyl-3-(2-phenylsulfanylethyl)thiourea | —— | C14H20N2S2 |
|
—— | 4-[(5S)-5-(thiophen-2-ylsulfanylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C12H16N2OS3 |
|
—— | methyl (2R)-2-(4-cyanopyridin-2-yl)sulfanyl-2-(4-fluorophenyl)acetate | —— | C15H11FN2O2S |
|
—— | tert-butyl N-(2-phenylsulfanylethylcarbamothioylamino)carbamate | —— | C14H21N3O2S2 |
|
—— | 1-Cycloheptyl-3-(2-phenylsulfanylethyl)thiourea | —— | C16H24N2S2 |
|
—— | 4-acetyl-N-[2-(4-chlorophenyl)sulfanylethyl]piperazine-1-carbothioamide | —— | C15H20ClN3OS2 |
|
—— | N-[2-(4-chlorophenyl)sulfanylethyl]-4-ethylpiperazin-4-ium-1-carbothioamide | —— | C15H23ClN3S2+ |
|
—— | methyl (2R)-2-[(4-tert-butyl-1,2,4-triazol-3-yl)sulfanyl]-2-(4-fluorophenyl)acetate | —— | C15H18FN3O2S |
|
—— | N-[2-(4-chlorophenyl)sulfanylethyl]-4-methylpiperidine-1-carbothioamide | —— | C15H21ClN2S2 |
|
—— | methyl (2R)-2-[[5-(3-methylthiophen-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-2-phenylacetate | —— | C16H14N2O3S2 |
|
—— | methyl (2R)-2-phenyl-2-[[5-(thiophen-2-ylmethyl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetate | —— | C16H14N2O3S2 |
|
—— | methyl (2R)-2-(4-fluorophenyl)-2-(1,3-thiazol-2-ylsulfanyl)acetate | —— | C12H10FNO2S2 |
|
—— | 1-[2-(4-Chlorophenyl)sulfanylethyl]-3-propan-2-ylthiourea | —— | C12H17ClN2S2 |
|
—— | N-[2-(4-chlorophenyl)sulfanylethyl]pyrrolidine-1-carbothioamide | —— | C13H17ClN2S2 |
|
—— | 1-[(2R)-butan-2-yl]-3-[2-(4-chlorophenyl)sulfanylethyl]thiourea | —— | C13H19ClN2S2 |
|
—— | methyl (2S)-2-(4-fluorophenyl)-2-(1,3-thiazol-2-ylsulfanyl)acetate | —— | C12H10FNO2S2 |
|
—— | 4-[(5R)-5-(thiophen-2-ylsulfanylmethyl)-4,5-dihydro-1,3-thiazol-2-yl]morpholine | —— | C12H16N2OS3 |
|
—— | 1-(2-Phenylsulfanylethyl)-3-(2,2,6,6-tetramethylpiperidin-1-ium-4-yl)thiourea | —— | C18H30N3S2+ |
|
—— | N-[2-(4-chlorophenyl)sulfanylethyl]-4-ethylpiperazine-1-carbothioamide | —— | C15H22ClN3S2 |
|
—— | methyl (2S)-2-[(4-tert-butyl-1,2,4-triazol-3-yl)sulfanyl]-2-(4-fluorophenyl)acetate | —— | C15H18FN3O2S |
|
—— | N-[2-(4-chlorophenyl)sulfanylethyl]azepane-1-carbothioamide | —— | C15H21ClN2S2 |
|
—— | N-[2-(4-chlorophenyl)sulfanylethyl]piperidine-1-carbothioamide | —— | C14H19ClN2S2 |
|
—— | (3S)-1-(1,1-dioxo-1,4-thiazepan-4-yl)-3-ethylheptan-1-one | —— | C14H27NO3S |
|
—— | (3R)-1-(1,1-dioxo-1,4-thiazepan-4-yl)-3-ethylheptan-1-one | —— | C14H27NO3S |
|
—— | (2R)-N-(3-methoxypropyl)-2-thiophen-2-ylsulfanylpropanamide | —— | C11H17NO2S2 |
|
—— | (2R)-N-[(2R)-2-cyano-3-methylbutan-2-yl]-2-thiophen-2-ylsulfanylpropanamide | —— | C13H18N2OS2 |
|
—— | (2S)-N-(3-methoxypropyl)-2-thiophen-2-ylsulfanylpropanamide | —— | C11H17NO2S2 |
|
—— | 2-(2-methylpropyl)-5-[(1R)-1-thiophen-2-ylsulfanylethyl]-1,3,4-oxadiazole | —— | C12H16N2OS2 |
|
—— | 2-(2-methylpropyl)-5-[(1S)-1-thiophen-2-ylsulfanylethyl]-1,3,4-oxadiazole | —— | C12H16N2OS2 |
|
—— | (2S)-N-(2-cyanoethyl)-N-methyl-2-thiophen-2-ylsulfanylpropanamide | —— | C11H14N2OS2 |
|
—— | (2S)-2-thiophen-2-ylsulfanyl-N-(2,2,2-trifluoroethyl)propanamide | —— | C9H10F3NOS2 |
|
—— | (2R)-N-[(2S)-2-cyano-3-methylbutan-2-yl]-2-thiophen-2-ylsulfanylpropanamide | —— | C13H18N2OS2 |
|
—— | (2R)-N-(2-cyanoethyl)-N-methyl-2-thiophen-2-ylsulfanylpropanamide | —— | C11H14N2OS2 |
|
—— | (2S)-N-[(2S)-2-cyano-3-methylbutan-2-yl]-2-thiophen-2-ylsulfanylpropanamide | —— | C13H18N2OS2 |
|
—— | 1-[2-[(R)-methylsulfinyl]ethyl]-3-[(2-phenylsulfanylphenyl)methyl]urea | —— | C17H20N2O2S2 |
|
—— | 1-[2-[(S)-methylsulfinyl]ethyl]-3-[(2-phenylsulfanylphenyl)methyl]urea | —— | C17H20N2O2S2 |
|
—— | N-[[(2R)-1,4-dimethylpiperazin-2-yl]methyl]-1-phenylsulfanylcyclopentane-1-carboxamide | —— | C19H29N3OS |
|
—— | N-[(1S,3S)-1-cyano-3-methylcyclohexyl]-2-propylsulfonylacetamide | —— | C13H22N2O3S |
|
—— | N-[(1R,3R)-1-cyano-3-methylcyclohexyl]-2-propylsulfonylacetamide | —— | C13H22N2O3S |
|